Paris, France

Cyril Goizet

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: National Institute of Health and Medical Research. Active years: 2016.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Cyril Goizet

Introduction

Cyril Goizet is a notable inventor based in Paris, France. He has made significant contributions to the field of genetics, particularly in the diagnosis of hereditary conditions. His work has implications for understanding and treating hereditary spastic paraplegias (HSP).

Latest Patents

Cyril Goizet holds a patent for the "Diagnosis of hereditary spastic paraplegias (HSP) by identification of a mutation in the ZFYVE26 gene or protein." This invention relates to an ex vivo method of diagnosing or predicting HSP in a subject. The method involves detecting a mutation in the ZFYVE26 gene or protein, known as spastizin, which indicates the presence of hereditary spastic paraplegias.

Career Highlights

Throughout his career, Cyril Goizet has worked with esteemed institutions such as the National Institute of Health and Medical Research and the Université de Bordeaux. His research has focused on genetic mutations and their implications for hereditary diseases, showcasing his commitment to advancing medical science.

Collaborations

Cyril has collaborated with notable colleagues, including Elodie Martin and Giovanni Stevanin. These partnerships have contributed to the depth and breadth of his research in the field of genetics.

Conclusion

Cyril Goizet's innovative work in diagnosing hereditary spastic paraplegias highlights the importance of genetic research in medicine. His contributions continue to pave the way for advancements in understanding and treating genetic disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…